Years of Understaffing Exposed (Image Credits: Unsplash)
A recent Government Accountability Office evaluation exposed persistent staffing gaps at the Food and Drug Administration, hindering the agency’s ability to regulate a massive array of products central to American life.[1][2]
Years of Understaffing Exposed
The FDA grappled with workforce shortages long before recent assessments. Investigators dedicated to food safety inspections operated at just 90 percent of their authorized full-time equivalent levels as of July 2024, with only 432 personnel available for both domestic and foreign duties.[2]
Agency officials pinpointed limited workforce capacity as the top barrier to fulfilling inspection mandates. These deficiencies persisted despite broader staffing growth in some areas from fiscal year 2008 through 2024.[3]
The latest GAO analysis, released February 3, underscored that the FDA lacked sufficient personnel to oversee nearly $4 trillion worth of food, cosmetics, medications, medical devices, and tobacco products sold annually in the United States.[1]
Food Inspections Fall Short of Targets
Domestic and foreign food facility checks suffered most from these constraints. The FDA failed to meet congressionally mandated inspection goals every year since fiscal 2018.[2]
For high-risk domestic facilities, the agency aimed to inspect each at least once every three years under the Food Safety Modernization Act. Yet uninspected high-risk sites climbed from 7 percent in fiscal 2019 to 49 percent in fiscal 2021.[2]
Foreign inspections lagged even further. Lawmakers set an annual target of 19,200 reviews, but the FDA peaked at 1,727 in fiscal 2019 and averaged 917 per year from 2018 through 2023.[2]
- Average annual domestic food inspections: 8,353 from fiscal years 2018-2023.
- Primary culprit: Understaffed investigator teams strained by pandemic disruptions and resource limits.
- Outcome: Heightened risks from unexamined facilities supplying fruits, seafood, and processed foods.
Recent Cuts Amplify the Crisis
Staffing reductions exacerbated the problem in late 2025. ProPublica investigations revealed record lows in foreign food safety checks, linked directly to personnel and travel budget slashes.[4][5]
Inspectors documented severe sanitation issues, including insects and contaminated equipment, at overseas factories exporting to the U.S. Current and former FDA staff attributed the downturn to deliberate cuts affecting oversight of imported produce and seafood.[5]
These lapses occurred as the FDA managed a portfolio representing 21 cents of every consumer dollar spent in 2024.[1]
Path Forward Demands Urgent Reforms
GAO outlined concrete steps to address the shortfalls. The agency urged the FDA to calculate optimal foreign investigator numbers based on risks, resources, and priorities.[2]
FDA officials agreed with proposals to refine domestic inspection protocols, bolster performance tracking for recruitment and retention, and communicate realistic foreign targets to Congress.
| Inspection Category | Target Frequency | Recent Performance |
|---|---|---|
| High-Risk Domestic | Every 3 years | Up to 49% missed (2021) |
| Non-High-Risk Domestic | Every 5 years | Below targets since 2018 |
| Foreign Facilities | 19,200 annually | Avg. 917/year (2018-2023) |
- Persistent understaffing at 90% capacity limits core FDA functions.
- Food inspection shortfalls expose consumers to contamination risks.
- GAO recommendations target workforce planning and accountability.
These revelations signal a pivotal moment for bolstering the FDA’s capacity to protect public health amid evolving threats. What steps should lawmakers take next to ensure robust food safety? Share your thoughts in the comments.
